PL2295086T3 - Sposób zmniejszania skażenia pankreatyny wirusami i drobnoustrojami - Google Patents

Sposób zmniejszania skażenia pankreatyny wirusami i drobnoustrojami

Info

Publication number
PL2295086T3
PL2295086T3 PL10150773T PL10150773T PL2295086T3 PL 2295086 T3 PL2295086 T3 PL 2295086T3 PL 10150773 T PL10150773 T PL 10150773T PL 10150773 T PL10150773 T PL 10150773T PL 2295086 T3 PL2295086 T3 PL 2295086T3
Authority
PL
Poland
Prior art keywords
pancreatin
viruses
organs
contamination
micro
Prior art date
Application number
PL10150773T
Other languages
English (en)
Inventor
Manfred Kurfürst
Christian Rämsch
Thomas Schräder
Thomas Moest
Original Assignee
Nordmark Arzneimittel Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40225499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2295086(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nordmark Arzneimittel Gmbh & Co Kg filed Critical Nordmark Arzneimittel Gmbh & Co Kg
Publication of PL2295086T3 publication Critical patent/PL2295086T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/94—Pancreatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
PL10150773T 2008-11-03 2008-11-03 Sposób zmniejszania skażenia pankreatyny wirusami i drobnoustrojami PL2295086T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08019210 2008-11-03
EP10150773A EP2295086B1 (de) 2008-11-03 2008-11-03 Verfahren zur Verringerung der viralen und mikrobiellen Belastung von Pankreatin

Publications (1)

Publication Number Publication Date
PL2295086T3 true PL2295086T3 (pl) 2012-09-28

Family

ID=40225499

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10150773T PL2295086T3 (pl) 2008-11-03 2008-11-03 Sposób zmniejszania skażenia pankreatyny wirusami i drobnoustrojami

Country Status (6)

Country Link
US (1) US8283147B2 (pl)
EP (1) EP2295086B1 (pl)
AT (1) ATE541591T1 (pl)
DE (1) DE102008056551A1 (pl)
ES (1) ES2385958T3 (pl)
PL (1) PL2295086T3 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US8100844B2 (en) * 2002-04-25 2012-01-24 Ultraflex Systems, Inc. Ambulating ankle and knee joints with bidirectional dampening and assistance using elastomeric restraint
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US20090324730A1 (en) * 2008-06-26 2009-12-31 Fallon Joan M Methods and compositions for the treatment of symptoms of complex regional pain syndrome
PL2318035T3 (pl) 2008-07-01 2019-10-31 Curemark Llc Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
CA2747703C (en) 2009-01-06 2021-06-15 Curemark Llc Compositions and methods for the treatment or the prevention of infections by e. coli
JP5684725B2 (ja) 2009-01-06 2015-03-18 キュレロン リミテッド ライアビリティ カンパニー 黄色ブドウ球菌感染の治療または予防のための組成物および方法ならびに表面上にいる黄色ブドウ球菌の根絶または低減のための組成物および方法
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
DK2701733T3 (da) 2011-04-21 2019-05-27 Curemark Llc Forbindelser til behandling af neuropsykiatriske forstyrrelser
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
EP3298139B1 (en) 2015-05-19 2021-09-15 Scientific Protein Laboratories LLC Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin
DE102015119006A1 (de) 2015-11-05 2017-05-11 Nordmark Arzneimittel Gmbh & Co. Kg Verfahren zur Reduzierung der Belastung von Pankreatin mit Mikroorganismen
ES2970869T3 (es) * 2016-03-28 2024-05-31 Abbott Laboratories Gmbh Composiciones enzimáticas con contaminación vírica y microbiana reducida
US11278603B2 (en) 2016-03-28 2022-03-22 Abbvie Inc. Enzyme compositions with reduced viral and microbial contamination
WO2018191233A1 (en) 2017-04-10 2018-10-18 Curemark, Llc Compositions for treating addiction
BR112020006211A2 (pt) * 2017-09-27 2020-10-13 Abbott Laboratories Gmbh preparação de enzima produzida por um método, preparação de enzima, método para produzir um produto de pancreatina, composição farmacêutica e método para tratar insuficiência pancreática exócrina
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA394981A (en) * 1941-03-04 The Griffith Laboratories Pancreatin sterilization
US3956483A (en) * 1968-10-24 1976-05-11 Wilson Pharmaceutical & Chemical Corporation Preparing pancreatin
GB1342409A (en) * 1970-07-23 1974-01-03 Ciba Geigy Ag Flowable pancreatin preparation of low microorgan ism content and a process for its manufacture
DE2106706B2 (de) * 1971-02-12 1973-05-10 Wilson Pharmaceutical & Chemical Corp., Chicago, 111. (V.St.A.) Verfahren zur herstellung von pankreatin als trockenes pulver mit hoher proteolytischer, amylolytischer und lipolytischer aktivitaet
DE3248588A1 (de) 1982-12-30 1984-07-12 Nordmark-Werke Gmbh, 2000 Hamburg Verfahren zur gewinnung von pankreatin von hohem schuettgewicht
DE4227385A1 (de) * 1992-08-19 1994-02-24 Kali Chemie Pharma Gmbh Pankreatinmikropellets
AU2002246493A1 (en) 2000-08-10 2002-07-30 Boston Biomedica, Inc. Pressure cycling inactivation of pathogens in biological materials used for therapeutics or vaccines
PL2278002T3 (pl) * 2005-07-29 2017-12-29 Abbott Laboratories Gmbh Pankreatyna o zmniejszonej zawartości wirusowej

Also Published As

Publication number Publication date
DE102008056551A1 (de) 2010-05-06
EP2295086A1 (de) 2011-03-16
EP2295086B1 (de) 2012-01-18
US8283147B2 (en) 2012-10-09
ATE541591T1 (de) 2012-02-15
US20090233344A1 (en) 2009-09-17
ES2385958T3 (es) 2012-08-06

Similar Documents

Publication Publication Date Title
ATE541591T1 (de) Verfahren zur verringerung der viralen und mikrobiellen belastung von pankreatin
Giannakis et al. Solar disinfection is an augmentable, in situ-generated photo-Fenton reaction—Part 2: A review of the applications for drinking water and wastewater disinfection
UA93384C2 (ru) Способ получения стерилизированного порошкообразного панкреатина
MY151119A (en) Duck embryonic derived stem cell lines for the production of viral vaccines
WO2013039861A3 (en) Engineered nucleic acids and methods of use thereof
BRPI1000098A2 (pt) filtro orgánico plantado com canas europeias e/ou tropicais/desérticas para o tratamento de águas, solos ou ar poluìdos
NO20081329L (no) Fremstilling av modifiserte lignocellulosematerialer
NZ596142A (en) Processing biomass
EP2465919A3 (en) Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
WO2010014976A3 (en) Microbial treatment of lignocellulosic biomass
EA201492061A1 (ru) Обработка биомассы
WO2013058594A3 (ko) 항염 활성을 갖는 발효녹용 추출물의 제조 방법, 이로부터 얻어진 추출물 및 이러한 추출물의 용도
NO20083436L (no) Kjemisk papirmassebehandling, sammensetning og metoder
WO2007062028A8 (en) Treatment of qt interval prolongation and diseases associated therewith
WO2009015663A3 (de) Trocknungsverfahren innerhalb der sauren hydrolyse von pflanzlichen biomassen
EA200900637A1 (ru) Способ повышения сухой биомассы растений
NO20062275L (no) Fremgangsmate for a modifisere stivelse og stivelsesderivater
MX2011009056A (es) Proceso para la preparacio de ajoeno.
EP1759715A4 (en) STERILIZATION SYSTEM
PL1654284T3 (pl) Sposób uzyskiwania roztworu alfa-1-antytrypsyny
WO2009130181A3 (en) Dry transglutaminase composition
WO2008122636A3 (en) Steam or water treatment of a catalyst precursor in order to obtain an egg shell ft catalyst
UA103158C2 (ru) Конъюгат белок-полимер и способ лечения с его помощью
CN109205691A (zh) 一种工业废水处理剂及其制备工艺
DE60327237D1 (de) Dc-sign blockern und deren verwendung zur vorbeugung oder behandlung von viraleninfektionen